quinidine has been researched along with Epilepsy in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 8 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| A Emmitte, K; M Qunies, A | 1 |
| Bansal, R; Choubey, M; Naik, N; Saxena, A; Sharma, G; Siddharthan, D | 1 |
| Chen, S; Fang, Z; Li, M; Wang, X; Xu, D; Yang, J | 1 |
| Hughes, E; Oates, S; Pal, DK | 1 |
| Liu, R; Sun, L; Wang, Q; Wang, Y; Wu, J | 1 |
| Hayashi, M; Hirasawa-Inoue, A; Matsumoto, N; Matsumura, Y; Mizuguchi, T; Shirai, K; Sugai, K; Takase, C; Watanabe, A; Watanabe, T | 1 |
| Clapcote, SJ; Cole, BA; Lippiat, JD; Muench, SP | 1 |
| Goldberg, EM | 1 |
| Baumer, FM; Sheehan, M | 1 |
| Meador, KJ; Shin, C | 1 |
| Millichap, JJ | 1 |
| Baumer, FM | 1 |
| Cilio, MR; Datta, AN; Gazina, E; Li, M; Nair, U; Numis, AL; Oldham, MS; Patel, A; Petrou, S; Sands, TT | 1 |
| de Lange, EC; Eriksson, J; Koepp, M; Labots, M; Lammertsma, AA; Potschka, H; Rongen, M; Russmann, V; Schuit, R; Seeger, N; Syvänen, S; van Kooij, R; Verbeek, J; Voskuyl, RA; Windhorst, AD; Zellinger, C | 1 |
| STERIADE, M; STOICA, E | 2 |
| Data, JL; Nies, AS; Wilkinson, GR | 1 |
| Edelman, M; Mielczarek-Bromboszcz, J; Zuchowska, J | 1 |
5 review(s) available for quinidine and Epilepsy
| Article | Year |
|---|---|
Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies.
Topics: Child; Epilepsy; Humans; Mutation; Nerve Tissue Proteins; Potassium Channel Blockers; Potassium Channels, Sodium-Activated; Quinidine; Seizures | 2022 |
Precision therapy with quinidine of KCNT1-related epileptic disorders: A systematic review.
Topics: Anticonvulsants; Epilepsy; Humans; Mutation; Nerve Tissue Proteins; Potassium Channels, Sodium-Activated; Quinidine; Seizures | 2022 |
New use for an old drug: quinidine in KCNT1-related epilepsy therapy.
Topics: Anticonvulsants; Epilepsy; Humans; Mutation; Nerve Tissue Proteins; Potassium Channels; Potassium Channels, Sodium-Activated; Quinidine | 2023 |
Targeting K
Topics: Animals; Epilepsy; Humans; Mutation; Nerve Tissue Proteins; Potassium Channels, Sodium-Activated; Quinidine | 2021 |
Rational Small Molecule Treatment for Genetic Epilepsies.
Topics: Anticonvulsants; Clinical Trials as Topic; Epilepsy; Genetic Testing; Genetic Therapy; Humans; NAV1.6 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Phenytoin; Potassium Channels, Sodium-Activated; Quinidine; Voltage-Gated Sodium Channel Blockers | 2021 |
13 other study(ies) available for quinidine and Epilepsy
| Article | Year |
|---|---|
Early repolarization syndrome, epilepsy, and atrial fibrillation in a young girl with novel KCND3 mutation managed with quinidine.
Topics: Atrial Fibrillation; China; Electrocardiography; Epilepsy; Epileptic Syndromes; Humans; Mutation; Quinidine; Shal Potassium Channels; Syncope | 2022 |
Intolerance to quinidine in a n-of-1 trial for KCNT1 associated epilepsy of infancy with migrating focal seizures.
Topics: Anticonvulsants; Child; Epilepsy; Humans; Nerve Tissue Proteins; Potassium Channels, Sodium-Activated; Quinidine; Seizures | 2022 |
KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.
Topics: Antitussive Agents; Dextromethorphan; Electroencephalography; Epilepsy; Humans; Infant; Magnetic Resonance Imaging; Male; Mutation; Nerve Tissue Proteins; Piperidines; Potassium Channels, Sodium-Activated; Quinidine; Seizures; Treatment Failure; Treatment Outcome | 2020 |
Quinidine-associated skin discoloration in
Topics: Epilepsy; Humans; Infant; Male; Nerve Tissue Proteins; Pigmentation Disorders; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Sodium-Activated; Quinidine | 2017 |
Pitfalls in developing precision medicine for genetic epilepsy.
Topics: Epilepsy; Genetic Therapy; Humans; Mutation; Nerve Tissue Proteins; Potassium Channels; Potassium Channels, Sodium-Activated; Precision Medicine; Quinidine | 2018 |
Reader response: Quinidine-associated skin discoloration in
Topics: Anticonvulsants; Child; Epilepsy; Humans; Nerve Tissue Proteins; Pigmentation Disorders; Potassium Channels; Potassium Channels, Sodium-Activated; Quinidine | 2018 |
Author response: Quinidine-associated skin discoloration in
Topics: Anticonvulsants; Child; Epilepsy; Humans; Nerve Tissue Proteins; Pigmentation Disorders; Potassium Channels; Potassium Channels, Sodium-Activated; Quinidine | 2018 |
Lack of response to quinidine in KCNT1-related neonatal epilepsy.
Topics: Animals; Anticonvulsants; Child, Preschool; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Kv1.1 Potassium Channel; Magnetic Resonance Imaging; Male; Membrane Potentials; Mutagenesis; Mutation; Oocysts; Patch-Clamp Techniques; Pharmacogenetics; Quinidine; Transduction, Genetic; Treatment Outcome; Xenopus | 2018 |
[11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Carbon Radioisotopes; Chronic Disease; Disease Models, Animal; Epilepsy; Female; Gene Expression Regulation; Kinetics; Male; Phenobarbital; Positron-Emission Tomography; Quinidine; Quinolines; Radiochemistry; Rats; Rats, Sprague-Dawley; Recurrence; Treatment Outcome | 2013 |
On the anticonvulsive effect of quinidine. I. Experimental investigation of somatomotor, vegetative and bioelectrical aspects of convulsive seizures elicited by electroshocks.
Topics: Electrophysiological Phenomena; Electroshock; Epilepsy; Humans; Quinidine; Seizures | 1960 |
On the anticonvulsive effect of quinidine. II. Experimental investigations of focal electrical after-discharge and penicillin epilepsy.
Topics: Epilepsy; Penicillins; Quinidine | 1960 |
Interaction of quinidine with anticonvulsant drugs.
Topics: Adult; Arrhythmias, Cardiac; Depression, Chemical; Drug Interactions; Enzyme Induction; Epilepsy; Female; Half-Life; Humans; Kinetics; Male; Phenobarbital; Phenytoin; Prothrombin Time; Quinidine | 1976 |
[Recurrent idiopathic ventricular fibrillation].
Topics: Diagnostic Errors; Electrocardiography; Epilepsy; Female; Humans; Middle Aged; Quinidine; Recurrence; Ventricular Fibrillation | 1971 |